vimarsana.com

Latest Breaking News On - Versiti blood research institute - Page 1 : vimarsana.com

Ponatinib Showcases Long-Term Efficacy, Safety in CP-CML With T315I Mutations

Ponatinib generated long-term efficacy and displayed manageable safety in chronic-phase chronic myeloid leukemia harboring a T315I mutation.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.